Further molecular studies in our PC346 cell line model revealed that, although gefitinib effectively blocked EGFR phosphorylation in PC cell lines, it failed to decrease the constitutively high Akt activity that is present in those PC lines that have a non-functional Pten (PC3, LNCaP, PC346C). The gene discussed is PTEN; the disease is pachyonychia congenita.